“…The results showed that renewable organs/tissues could be used as starting material for the production of PPAPs, thereby reducing the impact on the biodiversity. We also succeeded in isolating the guttiferone A ( 2 , Chart ) from the latex in large quantity, permitting its use in biological research. , Therefore, we decided to test the guttiferone A ( 2 ), structurally close to the guttiferone G, on SIRT1, and to carry out subsequent structure–activity relationship studies. Other PPAPs such as hyperforin ( 3 ) and its derivative aristoforin ( 4 , Chart ) were also included in the study to serve as positive control.…”